XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.4
BUSINESS COMBINATIONS - Preliminary fair value of assets acquired and liabilities assumed (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
May 03, 2021
HistoTox Labs    
Assets acquired and liabilities assumed:    
Trade receivables and contract assets $ 977  
Unbilled receivables 337  
Operating lease right of use ("ROU") asset 2,239  
Property and equipment 3,929  
Intangible assets 8,300  
Goodwill 9,339  
Accounts payable (150)  
Accrued expenses (136)  
Customer advances (207)  
Current portion on long-term operating lease (2,239)  
Total 22,389  
Bolder BioPATH    
Assets acquired and liabilities assumed:    
Cash.   $ 500
Trade receivables and contract assets 2,146  
Unbilled receivables 1,798  
Operating lease right of use ("ROU") asset 2,750  
Property and equipment 6,523  
Intangible assets 12,700  
Other assets 34  
Goodwill 36,206  
Accounts payable (153)  
Accrued expenses (243)  
Deferred revenue (662)  
Deferred tax liabilities (4,867)  
Current portion on long-term operating lease (2,750)  
Total 53,482  
Gateway Pharmacology Laboratories LLC    
Assets acquired and liabilities assumed:    
Trade receivables and contract assets 409  
Operating lease right of use ("ROU") asset 120  
Property and equipment 359  
Intangible assets 100  
Other assets 4  
Goodwill 2,260  
Accounts payable (3)  
Accrued expenses (72)  
Deferred tax liabilities (171)  
Current portion on long-term operating lease (120)  
Total 2,886  
BioReliance Corporation    
Assets acquired and liabilities assumed:    
Property and equipment 175  
Intangible assets 640  
Total 815  
Plato BioPharma Inc    
Assets acquired and liabilities assumed:    
Cash. 1,027  
Trade receivables and contract assets 853  
Prepaid expenses and other current assets 133  
Operating lease right of use ("ROU") asset 2,272  
Property and equipment 1,127  
Intangible assets 4,800  
Goodwill 9,279  
Accounts payable (113)  
Deferred tax liabilities (1,457)  
Accrued expenses and other liabilities (343)  
Long-term operating leases, net (2,272)  
Total 15,306  
Envigo RMS Holding Corp    
Assets acquired and liabilities assumed:    
Cash. 2,488  
Restricted cash 435  
Trade receivables and contract assets 43,566  
Inventories 40,000  
Prepaid expenses and other current assets 17,373  
Operating lease right of use ("ROU") asset 13,229  
Property and equipment 106,338  
Other assets 7,676  
Goodwill 282,768  
Accounts payable (25,832)  
Deferred tax liabilities (77,291)  
Fees invoiced in advance (7,047)  
Other liabilities (5,339)  
Current portion on long-term operating lease (4,371)  
Accrued expenses and other liabilities (11,665)  
Long-term operating leases, net (8,634)  
Noncontrolling interest 880  
Total 674,574  
Robinson Services, Inc.    
Assets acquired and liabilities assumed:    
Customer relationship 4,700  
Non-complete agreement 300  
Supply agreement 200  
Goodwill 948  
Total 6,148  
Integrated Laboratory Systems, LLC (ILS)    
Assets acquired and liabilities assumed:    
Cash. 797  
Trade receivables and contract assets 4,730  
Operating lease right of use ("ROU") asset 4,994  
Property and equipment 4,436  
Intangible assets 22,300  
Goodwill 25,283  
Accounts payable (1,165)  
Fees invoiced in advance (2,472)  
Accrued expenses and other liabilities (905)  
Long-term operating leases, net (4,554)  
Total 53,444  
Orient BioResource Center, Inc    
Assets acquired and liabilities assumed:    
Cash. 5,481  
Trade receivables and contract assets 2,025  
Inventories 9,400  
Prepaid expenses and other current assets 2,609  
Property and equipment 8,336  
Intangible assets 13,400  
Goodwill 18,624  
Accounts payable (552)  
Deferred tax liabilities (3,216)  
Fees invoiced in advance (6,548)  
Accrued expenses and other liabilities (285)  
Total 49,274  
Protypia, Inc.    
Assets acquired and liabilities assumed:    
Intangible assets 9,600  
Other assets 50  
Goodwill 3,305  
Deferred tax liabilities (2,089)  
Total $ 10,866